Sufficient functional repair of damaged peripheral nerves is a big clinical challenge in terms of long-lasting morbidity, disability, and economic costs. Nerve damage after radical prostatectomy is the most common cause of erectile dysfunction. In recent years, low-intensity extracorporeal shockwave therapy has been explored to improve the outcomes of peripheral nerve repair and regeneration. Research indicated that application of low-intensity extracorporeal shockwave therapy after nerve surgery promoted nerve regeneration and improved the functional outcomes, underlined the mechanisms related to increase of neurotrophic factors, Schwann cells activation, and cellular signaling activation for cell activation and mitosis induced by low-intensity extracorporeal shockwave therapy. We searched PubMed for articles related to research on these topics in both in vitro and in vivo animal models and found numerous studies suggesting that the application low-intensity extracorporeal shockwave therapy could be a novel treatment for erectile dysfunction induced by nerve injury and other disease related to nerve injury.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.5152/tud.2022.20419 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Therapeutic management of erectile dysfunction: the AFU/SFMS guidelines.
Fr J Urol
December 2024
Department of Urology, Hospital of Monaco, France.
Context: Erectile dysfunction (ED) is a common sexual disorder. In France, recent evidence-based guidelines are lacking.
Aim: To provide practice guidelines on ED therapeutic management.
Stem cell assisted low-intensity shockwave for erectile dysfunction treatment: Current perspective.
Regen Ther
June 2024
Graduate School of Medicine, KPJ Healthcare University, Nilai 71800, Negeri Sembilan, Malaysia.
Stem cell therapy and low-intensity extracorporeal shockwave (LI-ECSW) are recognized as potential restorative therapies and have been used in the treatment of erectile dysfunction (ED). Stem cell therapy is well-known due to its attributed regenerative ability and thus can help to improve erectile function in patients with vasculogenic ED. Besides, current evidence also shows that LI-ECSW therapy can help stimulate cell recruitment and proliferation and promote angiogenesis and vascularization in the damaged tissue.
View Article and Find Full Text PDFIs low-intensity shockwave therapy for erectile dysfunction a durable treatment option?-long-term outcomes of a randomized sham-controlled trial.
Transl Androl Urol
October 2024
Department of Urology, University of Virginia, Charlottesville, VA, USA.
Background: Low-intensity shockwave therapy (LiSWT) is an emerging non-invasive and restorative therapy for erectile dysfunction (ED) with demonstrated efficacy and few adverse events. Although LiSWT has been shown to improve erectile function amongst men with ED, few studies have examined its long-term durability. We present the long-term results of a randomized controlled trial (RCT) assessing erectile function after LiSWT.
View Article and Find Full Text PDFRegenerative therapies for erectile dysfunction: a systematic review, Bayesian network meta-analysis, and meta-regression.
J Sex Med
December 2024
Scott Department of Urology, Baylor College of Medicine, Houston, TX, 77030, United States.
Background: Current guidelines advocate a shared decision-making process approach to erectile dysfunction management, and while there is growing interest in regenerative therapies such as stem cell therapy, platelet-rich plasma injections, and low-intensity shockwave therapy for erectile dysfunction, comparative data on the efficacy of these modalities are limited.
Aim: This systematic review and network meta-analysis aims to compare stem cell therapy, platelet-rich plasma injections, and low-intensity shockwave therapy for managing erectile dysfunction and quantify their impact on the International Index of Erectile Function (IIEF).
Methods: In January 2024, a systematic search of online databases was performed to identify randomized clinical trials related to stem cell therapy, platelet-rich plasma injections, and low-intensity shockwave therapy in erectile dysfunction.
Low-intensity extracorporeal shock wave therapy for Peyroniès disease: a systematic review and meta-analysis.
BMC Urol
October 2024
Department of Urology, Beijing Jishuitan Hospital, Capital Medical University, Xinjiekou East Street, West District, Beijing, 100035, China.
Article Synopsis
- A systematic review was conducted to evaluate the effectiveness of low-intensity extracorporeal shock wave therapy (LI-ESWT) for treating Peyronie’s Disease (PD) through data from various controlled studies published until February 2023.
- The analysis included 7 studies with 475 patients, showing that LI-ESWT significantly reduced penile plaques, improved curvature, alleviated pain, and even led to complete remission in some cases, but did not significantly improve sexual function compared to a placebo.
- The findings suggest LI-ESWT may be beneficial for some symptoms of PD, but further high-quality studies are needed for more conclusive evidence on its long-term effectiveness.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!